AbCellera's AI-driven drug discovery model hasn't translated into meaningful growth. Click here to read an analysis of ABCL ...

New Griffith University research investigated how the Nuralyte device, similar in size to an electric toothbrush, enhanced mitochondrial respiration and stimulated gene expression in bone-forming stem ...

But now, researchers at the University of New South Wales, Sydney have developed an enhanced way to make green ammonia through electrolysis. The researchers used machine learning to find an innovative ...

A research team led by Dr. Hye sun Cho at the Plant Systems Engineering Research Center of the Korea Research Institute of Bioscience and Biotechnology(KRIBB) has uncovered, for the first time at the ...

The new biotech facility is integrated into the group's research site in the Munich quarter of Sendling, where Wacker has been conducting research for over a century and, since the 1980s, research in ...

Meanwhile, biotech veteran Jean-Paul Kress, M.D. has stepped in as CEO and Chairman of the company, replacing Dr. Robert Ang, who will stay on as a strategic advisor through October.

Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.

Across the recent three months, 7 analysts have shared their insights on Krystal Biotech (NASDAQ:KRYS), expressing a variety of opinions spanning from bullish to bearish. The following table ...

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx Pharmaceuticals announced that the US FDA granted Fast Track designation to AMX0114.

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co.

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts By Adria Cimino – Jun 21, 2025 at 6:10PM ...